Affiliation:
1. College of Pharmacy, Rady Faculty of Health Sciences University of Manitoba Winnipeg Canada
2. Bangladesh Pharmacogenomics Research Network (BdPGRN) Dhaka Bangladesh
3. Department of Psychiatry, Max Rady College of Medicine University of Manitoba Winnipeg Canada
4. Department of Medical Epidemiology and Biostatistics Karolinska Institute Stockholm Sweden
5. The Mathison Centre for Mental Health Research & Education, Cumming School of Medicine, Department of Psychiatry University of Calgary Calgary Canada
Abstract
AbstractBackground and AimsPharmacists have been recognized as one of the most qualified healthcare professionals in the clinical implementation of pharmacogenomics, yet its widespread implementation in clinical pharmacy practice has remained limited. The review aims to systematically investigate knowledge, perceptions, and attitudes toward pharmacogenomics among pharmacists and pharmacy students to inform the future delivery of pharmacogenomics education programs.MethodsPubMed, MEDLINE, Embase, Scopus, and the International Pharmaceutical Abstracts were searched up to May 17, 2022. Studies were selected if they included data on pharmacists' or pharmacy students' knowledge, perception, or attitude about pharmacogenomics and were published in a peer‐reviewed, English‐language journal with full‐text availability. Any published study not deemed original research was excluded. All included studies were critically appraised using the Center for Evidence‐Based Management's critical appraisal tools. The data were descriptively analyzed and presented based on pharmacists' and pharmacy students' knowledge/awareness, perception/attitudes toward pharmacogenomic (PGx), confidence in using or interpreting PGx testing results, and their desire to get further PGx education or their most preferred method of further education.ResultsA combined total of 12,430 pharmacists and pharmacy students from 26 countries are represented in the 52 included studies. Despite overwhelmingly positive attitudes and perceptions toward pharmacogenomics among pharmacists and pharmacy students, an overall lack of adequate knowledge and confidence was found. The review also found a strong desire for further pharmacogenomics education among pharmacists and pharmacy students.ConclusionPharmacists and pharmacy students have positive perceptions and attitudes toward pharmacogenomics, which is hindered by a lack of knowledge and confidence. However, inadequate control for confounders, limited representativeness of the studied population or region, and small sample sizes diminish the generalizability of the review results. Knowledge and confidence could be improved through enhanced delivery of pharmacogenomic courses within the pharmacy curriculum and continuing education programs.
Reference93 articles.
1. The Independent. Glaxo Chief: Our Drugs Do Not Work on Most Patients. Published December 8 2003. Accessed June 29 2023.https://www.independent.co.uk/news/science/glaxo-chief-our-drugs-do-not-work-on-most-patients-5508670.html
2. Incidence of Adverse Drug Reactions in Hospitalized Patients
3. Center for Drug Evaluation and Research at the Food and Drug Administration. Preventable Adverse Drug Reactions: A Focus on Drug Interactions. Published online June 9 2021. Accessed July 30 2023.https://www.fda.gov/drugs/drug-interactions-labeling/preventable-adverse-drug-reactions-focus-drug-interactions
4. Adverse Drug Reaction Canada. Working to Prevent Canada's 4th Leading Cause of Death. Published July 9 2021. Accessed June 14 2023.https://adrcanada.org/
5. Pharmacogenomics: current status and future perspectives